4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-17-007791
CIK 0000792977operating
Filed
May 21, 8:00 PM ET
Accepted
May 22, 7:12 PM ET
Size
7.6 KB
Accession
0001179110-17-007791
Insider Transaction Report
Form 4
Deptula Barbara
Director
Transactions
- Award
Common Stock
2017-05-18+4,545→ 14,660 total - Award
Stock Option (Right to Buy)
2017-05-18+10,110→ 10,110 totalExercise: $19.25Exp: 2027-05-18→ Common Stock (10,110 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan (the "Plan") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
- [F2]Not applicable.
- [F3]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 7:12 PM ET
- Size
- 7.6 KB